Spectral Medical, Inc. (EDT.TO)
1.11
-0.07
(-5.93%)
CAD |
TSX |
Oct 05, 15:59
Spectral Medical Profit Margin (Quarterly) : 53.30% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 53.30% |
| March 31, 2026 | -329.4% |
| December 31, 2025 | -742.7% |
| September 30, 2025 | -4.49K% |
| June 30, 2025 | -237.8% |
| March 31, 2025 | -2.20K% |
| December 31, 2024 | |
| September 30, 2024 | -1.99K% |
| June 30, 2024 | -934.6% |
| March 31, 2024 | -622.3% |
| December 31, 2023 | -1.79K% |
| September 30, 2023 | -925.7% |
| June 30, 2023 | -1.40K% |
| March 31, 2023 | -206.6% |
| December 31, 2022 | -215.2% |
| September 30, 2022 | -647.2% |
| June 30, 2022 | -744.6% |
| March 31, 2022 | -420.7% |
| December 31, 2021 | -493.6% |
| September 30, 2021 | -898.7% |
| June 30, 2021 | -451.0% |
| March 31, 2021 | -220.5% |
| December 31, 2020 | -401.3% |
| September 30, 2020 | -377.3% |
| June 30, 2020 | -377.0% |
| Date | Value |
|---|---|
| March 31, 2020 | -542.8% |
| December 31, 2019 | -189.5% |
| September 30, 2019 | -262.4% |
| June 30, 2019 | -101.1% |
| March 31, 2019 | -181.5% |
| December 31, 2018 | 23.82% |
| September 30, 2018 | -122.5% |
| June 30, 2018 | -645.3% |
| March 31, 2018 | -61.39% |
| December 31, 2017 | -121.7% |
| September 30, 2017 | -104.5% |
| June 30, 2017 | -109.0% |
| March 31, 2017 | -109.1% |
| December 31, 2016 | -127.0% |
| September 30, 2016 | -326.3% |
| June 30, 2016 | -402.1% |
| March 31, 2016 | -281.9% |
| December 31, 2015 | -335.7% |
| September 30, 2015 | -367.2% |
| June 30, 2015 | -289.2% |
| March 31, 2015 | -258.3% |
| December 31, 2014 | -265.2% |
| September 30, 2014 | -312.9% |
| June 30, 2014 | -315.0% |
| March 31, 2014 | -376.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Resverlogix Corp. | -- |
| Theratechnologies, Inc. | -- |
| COSCIENS Biopharma, Inc. | -6.43% |
| Restart Life Sciences Corp. | -307.0% |
| Covalon Technologies Ltd. | 27.99% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -650.4% |
| Gross Profit Margin (Quarterly) | -186.3% |
| Operating Margin (Quarterly) | -352.3% |
| Return on Net Operating Assets | -2.37K% |